Full Text View
Tabular View
No Study Results Posted
Related Studies
The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study)
This study is ongoing, but not recruiting participants.
Study NCT00816907   Information provided by National Institute of Mental Health (NIMH)
First Received: January 2, 2009   Last Updated: November 13, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
Additional conditions recognized in this trial
Weight Gain
More general conditions related to this trial
Body Weight
Body Weight Changes
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Signs and Symptoms
Interventions listed in this trial
Metformin
Behavioral therapy
Placebo
Additional drug interventions recognized in this trial
Antipsychotic Agents
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Depressants
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
National Institute of Mental Health (NIMH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services